These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1444724)

  • 1. Anxiogenic effects of caffeine in patients with anxiety disorders.
    Bruce M; Scott N; Shine P; Lader M
    Arch Gen Psychiatry; 1992 Nov; 49(11):867-9. PubMed ID: 1444724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to 35% carbon dioxide in patients with generalized anxiety disorder.
    Perna G; Bussi R; Allevi L; Bellodi L
    J Clin Psychiatry; 1999 Jun; 60(6):379-84. PubMed ID: 10401916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects.
    Klein E; Zohar J; Geraci MF; Murphy DL; Uhde TW
    Biol Psychiatry; 1991 Nov; 30(10):973-84. PubMed ID: 1756202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic symptoms and physiologic responses in generalized anxiety disorder and panic disorder: an ambulatory monitor study.
    Hoehn-Saric R; McLeod DR; Funderburk F; Kowalski P
    Arch Gen Psychiatry; 2004 Sep; 61(9):913-21. PubMed ID: 15351770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between panic disorder and generalized anxiety disorder by 35% carbon dioxide challenge.
    Verburg K; Griez E; Meijer J; Pols H
    Am J Psychiatry; 1995 Jul; 152(7):1081-3. PubMed ID: 7793449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the cholecystokinin agonist pentagastrin in patients with generalized anxiety disorder.
    Brawman-Mintzer O; Lydiard RB; Bradwejn J; Villarreal G; Knapp R; Emmanuel N; Ware MR; He Q; Ballenger JC
    Am J Psychiatry; 1997 May; 154(5):700-2. PubMed ID: 9137133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality dimensions in panic disorder and generalized anxiety disorder.
    Starcevic V; Uhlenhuth EH; Fallon S; Pathak D
    J Affect Disord; 1996 Apr; 37(2-3):75-9. PubMed ID: 8731069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative electroencephalographic effects of caffeine in panic disorder.
    Newman F; Stein MB; Trettau JR; Coppola R; Uhde TW
    Psychiatry Res; 1992 Aug; 45(2):105-13. PubMed ID: 1488468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Event-related potentials in panic disorder and generalized anxiety disorder.
    Hanatani T; Sumi N; Taguchi S; Fujimoto O; Nan-No H; Takeda M
    Psychiatry Clin Neurosci; 2005 Feb; 59(1):83-8. PubMed ID: 15679545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects.
    Bruce M; Scott N; Lader M; Marks V
    Br J Clin Pharmacol; 1986 Jul; 22(1):81-7. PubMed ID: 3741730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caffeine challenge test and panic disorder: a systematic literature review.
    Vilarim MM; Rocha Araujo DM; Nardi AE
    Expert Rev Neurother; 2011 Aug; 11(8):1185-95. PubMed ID: 21797659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased anxiogenic effects of caffeine in panic disorders.
    Charney DS; Heninger GR; Jatlow PI
    Arch Gen Psychiatry; 1985 Mar; 42(3):233-43. PubMed ID: 2983630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anxiety sensitivity distinguishes panic disorder from generalized anxiety disorder.
    McNally RJ
    J Nerv Ment Dis; 1992 Nov; 180(11):737-8. PubMed ID: 1431831
    [No Abstract]   [Full Text] [Related]  

  • 14. DSM-III-R state anxiety symptoms in anxiety disorder patients.
    Bruce M; Lader M
    Biol Psychiatry; 1991 Sep; 30(5):519-22. PubMed ID: 1932399
    [No Abstract]   [Full Text] [Related]  

  • 15. [Psychophysiological characteristics of panic disorder and generalized anxiety disorder].
    Gordeev SA; Posokhov SI; Kovrov GV; Katenko SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(5):11-4. PubMed ID: 23739496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and utility of screening for depression and anxiety disorders in patients with cardiovascular disease.
    Celano CM; Suarez L; Mastromauro C; Januzzi JL; Huffman JC
    Circ Cardiovasc Qual Outcomes; 2013 Jul; 6(4):498-504. PubMed ID: 23759474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An examination of recent non-clinical panic attacks, panic disorder, anxiety sensitivity, and emotion regulation difficulties in the prediction of generalized anxiety disorder in an analogue sample.
    Tull MT; Stipelman BA; Salters-Pedneault K; Gratz KL
    J Anxiety Disord; 2009 Mar; 23(2):275-82. PubMed ID: 18804947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased sensitivity to caffeine in patients with panic disorders. Preliminary evidence.
    Boulenger JP; Uhde TW; Wolff EA; Post RM
    Arch Gen Psychiatry; 1984 Nov; 41(11):1067-71. PubMed ID: 6497568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stress test reactivity in panic disorder.
    Roth WT; Margraf J; Ehlers A; Taylor CB; Maddock RJ; Davies S; Agras WS
    Arch Gen Psychiatry; 1992 Apr; 49(4):301-10. PubMed ID: 1558464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and the N1/P2 auditory evoked response in man.
    Graham SJ; Scaife JC; Balboa Verduzco AM; Langley RW; Bradshaw CM; Szabadi E
    J Psychopharmacol; 2004 Jun; 18(2):173-80. PubMed ID: 15260904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.